67Ga scintigraphy in granulocytic sarcoma.

Area of Science:

• Hematology
• Oncology
• Nuclear Medicine

Background:

• Acute myelogenous leukemia (AML) patients can achieve hematologic remission.
• Extramedullary relapse of AML can occur, sometimes without obvious symptoms.

Observation:

• Granulocytic sarcomas (chloromas) developed in an AML patient during hematologic remission.
• A symptomatic lesion was diagnosed via open biopsy.
• Unsuspected lesions were detected using Gallium-67 citrate scintigraphy.

Findings:

• Gallium-67 citrate scans identified silent granulocytic sarcomas.
• Subsequent scans showed a positive response to treatment.
• The incidence and significance of these "silent" lesions in remission are currently unknown.

Implications:

• Detecting silent granulocytic sarcomas may aid in diagnosing extramedullary relapse.
• Early identification could facilitate targeted intensive local therapy.
• Further research is needed to understand the clinical significance of these findings.